top of page
Phoenix Atropine

Atropine sulphate 0.65mg/mL in a sterile solution for injection.


An anti-cholinergic alkaloid with both central and peripheral actions. It is anti-spasmodic on smooth muscle, and reduces salivary, bronchial and gastric secretions. It depresses the activity of the vagus nerve and increases the heart rate.


For preanaesthetic medication and the treatment of organophosphate poisoning


Glaucoma, cardiac insufficiency or cardiac failure.


Over-dosing causes tachycardia, rapid breathing, restlessness, depression of the central nervous system and excitement.



Dogs and cats

  • As a preanaesthetic adjuvant:
    0.02 – 0.04 mg/kg by IV, IM or SC routes.
  • For treatment of organophosphate poisoning:
    0.2 – 2.0 mg/kg to effect to achieve atropinisation; give 1/4th of the dose by slow IV and the remainder by IM or SC routes. Repeat every 3-6 hours as necessary until signs of poisoning are relieved.


Side Effects:
Dry mouth, dilation of pupils.


Special Precautions:
Do not get in eyes. See also Human First Aid below.


Human First Aid, Symptoms Of Poisoning:
If swallowed, DO NOT induce vomiting. For advice, contact a doctor or the National Poisons Centre (0800 POISON or 0800 764 766) immediately. If skin contact occurs, remove contaminated clothing and wash skin thoroughly. If splashed in eyes, hold eyelids apart and flush the eye continuously with running water. Continue flushing for at least 15 minutes. Symptoms of poisoning include dryness of mouth, dilated pupils and restlessness.

Other Information:
Store below 30°C. Keep out of reach of children.

Safety Data Sheet available upon request

Phoenix Atropine

    • Atropine sulphate 0.65mg/mL in a sterile solution for injection. 
    • Supplied in 50mL multi-dose vials.


    Product code: 9617


    Restricted Veterinary Medicine: A5436

bottom of page